Method of accelerated vaccination against Ebola viruses

US7635485B2 · kind B2 · utility

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Gary J. Nabel · Cambridge, US
• Nancy Sullivan · Kensington, US
• Thomas W. Geisbert · Albany, US
• Peter Jahrling · Middletown, US

Key dates

• Filing date: Jan 17, 2006
• Grant date: Dec 22, 2009
• Expiry date: Jan 17, 2026

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to genetic vaccines for stimulating cellular and humoral immune responses in humans and other hosts, and, in particular, relates to recombinant viruses that express heterologous antigens of pathogenic viruses, in single dose form.